Analysts have initiated coverage on JPMorgan Chase & Co. (NYSE: JPM), Lam Research Co. (NASDAQ: LRCX), Morgan Stanley (NYSE: MS), Myriad Genetics (NASDAQ: MYGN) and Rue21 (NYSE: RUE).
UBS AG (NYSE:UBS) initiated coverage on JPMorgan Chase & Co. (JPM). They placed a “buy” rating and a price target of $54.00 on the company.
Standpoint Research initiated coverage on Lam Research Co. (LRCX). They placed a “buy” rating and a price target of $60.00 on the company.
UBS AG initiated coverage on Morgan Stanley (MS). They placed a “neutral” rating and a price target of $28.00 on the company.
Auriga initiated coverage on Myriad Genetics (MYGN). They placed a “buy” rating and a price target of $27.00 on the company.
FBR Capital initiated coverage on Rue21 (RUE). They placed a “market perform” rating and a price target of $26.00 on the company.
Wednesday, May 4, 2011
Coverage On (JPM) (LRCX) (MS) (MYGN) (RUE) Initiated by Analysts
Labels:
JP Morgan,
Lam Research,
Morgan Stanley,
Myriad Genetics,
rue21
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment